Articles
| Open Access |
https://doi.org/10.37547/ijmscr/Volume06Issue01-07
T786C AND GLU298ASP Polymorphisms Of The Nos3 Gene And Their Association With Vascular Dysfunction In Patients With Coronary Heart Disease And Type 2 Diabetes Mellitus
Abstract
The impact of the T786C and Glu298Asp polymorphisms of the NOS3 gene on vascular reactivity parameters was assessed in patients with coronary artery disease and type 2 diabetes mellitus. Ninety-two patients were examined and genotyping was performed using PCR. Average linear blood flow velocity, arterial diameters before and after the functional test, and resistance and reactivity coefficients were studied. A significant decrease in vascular reactivity was found in carriers of the T/C and Glu/Asp genotypes compared to homozygotes. The identified patterns highlight the importance of NOS3 polymorphisms in the pathogenesis of vascular disorders in the combination of coronary heart disease and type 2 diabetes.
Keywords
Coronary heart disease, type 2 diabetes mellitus, endothelial dysfunction, NOS3 polymorphism
References
Mahmoudpour SH, et al. Association between NOS3 polymorphisms and cardiovascular diseases: a systematic review and meta-analysis. Sci Rep. 2019;9:13668.
Zhang X, et al. The impact of NOS3 gene polymorphisms on coronary artery disease risk: a meta-analysis. Int J Cardiol. 2018;252:162–169.
Ghasemi M, et al. Genetic variations of NOS3 and risk of metabolic syndrome. Gene. 2017;627:354–360.
Li H, et al. Endothelial dysfunction and nitric oxide: genetic insights. J Clin Med. 2020;9(7):2336.
Lima JAC, et al. Vascular function in diabetes: pathophysiological mechanisms and clinical implications. Circulation. 2021;143(6):557–574.
Wang Y, et al. Glu298Asp polymorphism and risk of type 2 diabetes-related complications. Diabetes Res Clin Pract. 2017;134:78–85.
Alvim RO, et al. NOS3 polymorphism and endothelial function in metabolic syndrome. BMC Cardiovasc Disord. 2018;18:57.
Trabetti E. The role of eNOS gene polymorphisms in hypertension. J Hypertens Res. 2020;6(1):34–42.
Serban C, et al. Inflammation and endothelial dysfunction in diabetes. Exp Ther Med. 2019;18(3):2471–2476.
Del Turco S, et al. Endothelial dysfunction markers in patients with diabetes. Nutrients. 2020;12(6):1834.
Thijssen DHJ, et al. Assessment of flow-mediated dilation in humans. Am J Physiol Heart Circ Physiol. 2019;316(1):H1–H12.
Zhang D, et al. Genetic polymorphisms of NOS3 in diabetic complications: a review. Biomed Rep. 2021;14(3):37.
Tang S, et al. Endothelial dysfunction in diabetes: the role of NO. Cardiovasc Diabetol. 2021;20:72.
Akbari M, et al. Polymorphisms in NOS3 and risk of vascular complications in T2DM. Diabetes Metab Syndr. 2020;14(6):1815–1821.
De Caterina R, et al. Nitric oxide signaling in cardiovascular health and disease. Mol Aspects Med. 2021;76:100870.
Reinders J, et al. NOS3 expression and genetic variants in vascular disease. Front Genet. 2020;11:595.
Zintzaras E, et al. eNOS polymorphisms and coronary artery disease: updated meta-analysis. J Hum Genet. 2017;62:831–841.
Tziomalos K, et al. Endothelial dysfunction in insulin resistance and T2DM. Curr Vasc Pharmacol. 2018;16(6):587–593.
Simonsen U, et al. Endothelial function in diabetes: new biomarkers. Diabetes Obes Metab. 2022;24(1):15–24.
Article Statistics
Copyright License
Copyright (c) 2026 Abdullaeva Charos Abdujalilovna, Juraev Mirzo Ibodulloevich, Zaxidova Mamura Umidjanovna, Mullaeva Sayyora Ilhomjonovna
This work is licensed under a Creative Commons Attribution 4.0 International License.